NCT02807129View on ClinicalTrials.gov

Fragmentation of Elastin as a Biological Marker of Frailty and Impact in Tumor Progression in Elderly Patients With Cancer

NACompletedINTERVENTIONAL
Enrollment

296

Participants

Timeline

Start Date

January 29, 2014

Primary Completion Date

January 16, 2023

Study Completion Date

January 16, 2023

Conditions
Cancer
Interventions
BIOLOGICAL

blood withdrawn

BIOLOGICAL

urine collection

Trial Locations (1)

51092

Damien JOLLY, Reims

All Listed Sponsors
lead

CHU de Reims

OTHER

NCT02807129 - Fragmentation of Elastin as a Biological Marker of Frailty and Impact in Tumor Progression in Elderly Patients With Cancer | Biotech Hunter | Biotech Hunter